87 related articles for article (PubMed ID: 647695)
1. Effects of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nornyl)adenine on plasma levels and urinary excretion of 9-beta-D-arabinofuranosyladenine in the mouse 1,2,3.
Suling WJ; Rice LS; Shannon WM
Cancer Treat Rep; 1978 Mar; 62(3):369-73. PubMed ID: 647695
[No Abstract] [Full Text] [Related]
2. Therapeutic effects of 9-beta-D-arabinofuranosyladenine and 2'-deoxycoformycin combinations on intracerebral leukemia.
Lee SH; Caron N; Kimball AP
Cancer Res; 1977 Jul; 37(7 Pt 1):1953-5. PubMed ID: 861931
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of brain adenosine deaminase by 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl) adenine.
Skolnick P; Nimitkitpaisan Y; Stalvey L; Daly JW
J Neurochem; 1978 Jun; 30(6):1479-82. PubMed ID: 670988
[No Abstract] [Full Text] [Related]
4. Biochemical basis of the increased activity of 9-beta-D-arabinofuranosyladenine in the presence of inhibitors of adenosine deaminase.
Plunkett W; Alexander L; Chubb S; Loo TL
Cancer Res; 1979 Sep; 39(9):3655-60. PubMed ID: 476690
[No Abstract] [Full Text] [Related]
5. Antiproliferative effects of 9-beta-D-arabinofuranosyladenine 5'-monophosphate and related compounds in combination with adenosine deaminase inhibitors against mouse leukemia L1210/C2 cells in culture.
Cass CE; Tan TH; Selner M
Cancer Res; 1979 May; 39(5):1563-9. PubMed ID: 85484
[TBL] [Abstract][Full Text] [Related]
6. Adenosine deaminase inhibition for immunosuppression.
Chassin MM; Chirigos MA; Johns DG; Adamson RH
N Engl J Med; 1977 May; 296(21):1232. PubMed ID: 854065
[No Abstract] [Full Text] [Related]
7. Enhancement of the antitumor activity of arabinofuranosyladenine of 2'-deoxycoformycin.
LePage GA; Worth LS; Kimball AP
Cancer Res; 1976 Apr; 36(4):1481-5. PubMed ID: 946595
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin.
Cass CE; Au-Yeung TH
Cancer Res; 1976 Apr; 36(4):1486-91. PubMed ID: 944095
[TBL] [Abstract][Full Text] [Related]
9. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.
Plunkett W; Cohen SS
Cancer Res; 1975 Jun; 35(6):1547-54. PubMed ID: 1079475
[TBL] [Abstract][Full Text] [Related]
10. Studies on the effects of infusion of enzyme inhibitors on mouse adenosine deaminase.
Trotta PP; Ahland MP; Brown GF; Balis ME
Mol Pharmacol; 1978 Jan; 14(1):199-209. PubMed ID: 625284
[No Abstract] [Full Text] [Related]
11. Comparison of the activity of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine in vivo.
Plunkett W; Alexander L; Chubb S; Loo TL
Biochem Pharmacol; 1979; 28(2):201-6. PubMed ID: 426835
[No Abstract] [Full Text] [Related]
12. Toxicities of adenosine and 2'-deoxyadrenosine in L cells treated with inhibitors of adenosine deaminase.
Lapi L; Cohen SS
Biochem Pharmacol; 1977 Jan; 26(1):71-6. PubMed ID: 299815
[No Abstract] [Full Text] [Related]
13. Studies of the relationship between adenosine deaminase and immune function.
Burridge PW; Paetkau V; Henderson JF
J Immunol; 1977 Aug; 119(2):675-8. PubMed ID: 301901
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of drug metabolism by a prodrug: 9-beta-D-arabinofuranosyladenine 5'-valerate as an inhibitor of adenosine deaminase.
Lipper RA; Machkovech SM; Drach JC; Higuchi WI
Mol Pharmacol; 1978 Mar; 14(2):366-9. PubMed ID: 642934
[No Abstract] [Full Text] [Related]
15. Increased toxicity of 9-beta-D-arabinofuranosyladenine in the presence of an inhibitor of adenosine deaminase.
Plunkett W; Cohen SS
Ann N Y Acad Sci; 1977 Mar; 284():91-102. PubMed ID: 280161
[No Abstract] [Full Text] [Related]
16. Enhancement of the biological activity of adenosine analogs by the adenosine deaminase inhibitor 2'-deoxycoformycin.
Adamson RH; Zaharevitz DW; Johns DG
Pharmacology; 1977; 15(1):84-9. PubMed ID: 840892
[TBL] [Abstract][Full Text] [Related]
17. Effect of an adenosine deaminase inhibitor on the uptake and metabolism of arabinosyl adenine (Vidarabine) by intact human erythrocytes.
Chang T; Glazko AJ
Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):127-40. PubMed ID: 935646
[TBL] [Abstract][Full Text] [Related]
18. Inhibition for immunosuppression.
Lum CT; Sutherland DE; Najarian JS
N Engl J Med; 1977 Apr; 296(14):819. PubMed ID: 320485
[No Abstract] [Full Text] [Related]
19. Distribution and inhibition of adenosine deaminase in tissues of man, rat, and mouse.
Ho DH; Pincus C; Carter CJ; Benjamin RS; Freireich EJ; Bodey GP
Cancer Treat Rep; 1980; 64(4-5):629-33. PubMed ID: 6968622
[TBL] [Abstract][Full Text] [Related]
20. Low-toxicity immunosuppression by specific inhibition of adenosine deaminase (ADA): prolongation of mouse skin grafts with erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA).
Lum CT; Sutherland DE; Foker JE; Najarian JS
Surg Forum; 1977; 28():320-2. PubMed ID: 364724
[No Abstract] [Full Text] [Related]
[Next] [New Search]
